COR THERAPEUTICS INC / DE
10-Q, EX-27.1, 2000-11-08
PHARMACEUTICAL PREPARATIONS
Previous: COR THERAPEUTICS INC / DE, 10-Q, EX-10.2, 2000-11-08
Next: CONSULTING GROUP CAPITAL MARKETS FUNDS, 497, 2000-11-08



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED BALANCE SHEETS, CONDENSED STATEMENTS OF OPERATIONS, AND CONDENSED
STATEMENTS OF CASH FLOWS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD
ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS AND THE NOTES THERETO.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          75,538
<SECURITIES>                                   264,486
<RECEIVABLES>                                    7,818
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               392,739
<PP&E>                                          26,301
<DEPRECIATION>                                (22,312)
<TOTAL-ASSETS>                                 406,602
<CURRENT-LIABILITIES>                           61,496
<BONDS>                                        300,000
                                0
                                          0
<COMMON>                                             5
<OTHER-SE>                                      43,131
<TOTAL-LIABILITY-AND-EQUITY>                   406,602
<SALES>                                              0
<TOTAL-REVENUES>                                72,891
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                93,782
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,284
<INCOME-PRETAX>                               (17,659)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (17,659)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (17,659)
<EPS-BASIC>                                    (.33)<F1>
<EPS-DILUTED>                                    (.33)
<FN>
<F1>For Purposes of this Exhibit, Primary means Basic.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission